Interpatient variation of clinical responses among acute lymphoblastic leukaemia (all) patients treated with 6-mercatopurine (6-MP): a pharmacogenomics - metabolomics perspective / Wan Rosalina Wan Rosli
Leukaemia chemotherapy had advanced considerably, enabling higher rates of survival and cure. This success is largely attributable to optimization of the use of chemotherapeutic agents such as 6-mercaptopurine (6-MP). How ever challenges still remain in striking a delicate balance between therapeuti...
Saved in:
| 主要作者: | |
|---|---|
| 格式: | Thesis |
| 語言: | English |
| 出版: |
2011
|
| 主題: | |
| 在線閱讀: | https://ir.uitm.edu.my/id/eprint/39782/1/39782.pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|